摘要翻译:本公开中,龙星病毒的分离是独特白蛉涉及鉴定和测序。 孤星病毒,蛋白质和抗体的核酸分子,中公开。 检测孤星病毒,诊断和治疗方法也被公开。 SEQ ID NO:1,或其互补物包含至少90%相同于SEQ ID NO:1的核酸序列和开放阅读框:2或SEQ ID NO:3,一种分离的核酸分子。 (A)SEQ ID NO:1,它们的互补,至少90%相同的核苷酸序列和SEQ ID NO:1的开放阅读框:2或SEQ ID NO:3;(B)SEQ ID NO:1,它们的互补,如SEQ ID NO:2或SEQ ID NO:3 所指示的核酸序列的开放阅读框;包含编码多肽,其包含或(c)显示为SEQ ID NO的氨基酸序列的核酸序列:4〜7的cDNA。
摘要:
Attenuated recombinant viruses containing DNA encoding an immunodeficiency virus and/or CTL antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: HIV1gag(+pro)(IIIB), gp120(MN)(+transmembrane), nef(BRU)CTL, pol(IIIB)CTL, ELDKWA or LDKW epitopes, preferably HIV1gag(+pro)(IIIB), gp120(MN) (+transmembrane), two (2) nef(BRU)CTL and three (3) pol(IIIB)CTL epitopes; or two ELDKWA in gp120 V3 or another region or in gp160. The two (2) nef(BRU)CTL and three (3) pol(IIIB)CTL epitopes are preferably CTL1, CTL2, pol1, pol2 and pol3. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. DNA from the recombinant viruses are useful as probes or, for generating PCR primers or for immunization. Also disclosed and claimed are HIV immunogens and modified gp160 and gp120.
摘要:
What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from flavivirus, such as Japanese encephalitis virus, yellow fever virus and Dengue virus. In a preferred embodiment, the recombinant poxvirus generates an extracellular particle containing flavivirus E and M proteins capable of inducing neutralizing antibodies, hemagglutination-inhibiting antibodies and protective immunity against flavivirus infection. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
摘要:
PROBLEM TO BE SOLVED: To provide a recombinant poxvirus-calicivirus such as RHDV and product derived from the recombinant virus. SOLUTION: The invention provides an attenuated recombinant virus containing a DNA encoding a calicivirus antigen such as an RHDV antigen, e.g., a capsid gene, and a method and a composition using the virus, expression product from the virus and an antibody generated from the virus or the expression product. The recombinant virus may be an NYVAC or ALVAC recombinant virus. The recombinant virus and gene product therefrom and antibody generated by the virus and gene product have several preventive, therapeutic and diagnostic uses. The DNA from the virus can be used for probes or for primers. COPYRIGHT: (C)2007,JPO&INPIT
摘要:
PROBLEM TO BE SOLVED: To provide a recombinant pox virus capable of expressing a gene product which is given by suitably treating flavivirus, and to provide a method for producing the recombinant pox virus. SOLUTION: This recombinant pox virus contains a heterologous DNA obtained from the flavivirus, such as a Japanese encephalitis virus, a yellow fever virus, and a dengue virus, wherein a vaccinia virus, a fowlpox virus or a canarypox virus is exemplified as the recombinant pox virus. It is preferable that the recombinant pox virus produces extracellular particles containing a flavivirus E and a M protein which induce a neutralizing antibody, a hemagglutination inhibitory antibody, and protective immunity against flavivirus infection. Further, a vaccine containing the recombinant pox virus which induces immunological response in a vaccinated host animal is provided. COPYRIGHT: (C)2004,JPO